हाइपोपैराथायरायडिज्म: जब पारंपरिक सक्रिय विटामिन डी थेरेपी से लक्ष्य कैल्शियम नियंत्रण प्राप्त नहीं हुआ हो तो क्या करें

References

DOI: 10.1093/ejendo/lvaf222

Doses of palopegteriparatide are adjusted according to calcium levels with up or down titration once a week (with a maximum change of ±3 μg/day each week).

We suggest to titrate the dose of PTH replacement therapy to achieve sustained calcium levels in the target range without the need for concurrent activated vitamin D treatment or calcium supplements.

If PTH replacement therapy is initiated, we suggest evaluating the treatment effects after 6–12 months, depending on treatment goals.